ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 143,300
+2,200 (1.56%)
Apr 10, 2026, 3:30 PM KST
ST Pharm Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 54,992 | 34,712 | 19,581 | 18,000 | 3,312 |
Depreciation & Amortization | 29,881 | 25,582 | 23,027 | 17,600 | 14,414 |
Loss (Gain) From Sale of Assets | 328.52 | 1,692 | 0.62 | 515.43 | 2,543 |
Asset Writedown & Restructuring Costs | -60.5 | -47.79 | - | - | - |
Loss (Gain) From Sale of Investments | -6,870 | -12,390 | 8,063 | 628.83 | -147.24 |
Stock-Based Compensation | 1,542 | 3,246 | 5,298 | 5,019 | 2,116 |
Provision & Write-off of Bad Debts | 1,715 | 3.87 | 188.27 | -0.06 | -138.94 |
Other Operating Activities | 11,843 | 19,948 | 9,920 | 6,088 | 6,619 |
Change in Accounts Receivable | -30,529 | 53,012 | -25,749 | -47,568 | -6,471 |
Change in Inventory | -52,821 | -12,944 | -13,226 | -25,939 | -37,301 |
Change in Accounts Payable | 1,295 | -7,321 | -369.93 | 6,071 | 8,169 |
Change in Other Net Operating Assets | 2,674 | 3,958 | -25,435 | 26,615 | 14,154 |
Operating Cash Flow | 13,989 | 109,451 | 1,298 | 7,031 | 7,270 |
Operating Cash Flow Growth | -87.22% | 8329.82% | -81.53% | -3.29% | - |
Capital Expenditures | -47,072 | -82,806 | -43,244 | -60,479 | -51,792 |
Sale of Property, Plant & Equipment | 51.6 | 168.5 | 100.94 | 3.67 | 612.72 |
Sale (Purchase) of Intangibles | -213.64 | -238.11 | -198.7 | 108.52 | -125.09 |
Investment in Securities | 17,089 | -8,021 | -40,708 | 54,085 | 42,492 |
Other Investing Activities | 3,819 | 4,354 | 1,662 | 557.09 | 779.23 |
Investing Cash Flow | -26,326 | -86,543 | -82,388 | -5,724 | -8,034 |
Short-Term Debt Issued | 11,479 | 25,000 | 25,878 | 20,000 | - |
Long-Term Debt Issued | - | 190.16 | 101,454 | 16,500 | - |
Total Debt Issued | 11,479 | 25,190 | 127,332 | 36,500 | - |
Short-Term Debt Repaid | - | - | -33,333 | - | - |
Long-Term Debt Repaid | -20,900 | -25,890 | -1,861 | -16,750 | -1,019 |
Total Debt Repaid | -20,900 | -25,890 | -35,195 | -16,750 | -1,019 |
Net Debt Issued (Repaid) | -9,421 | -699.68 | 92,137 | 19,750 | -1,019 |
Dividends Paid | -10,076 | -9,404 | -9,404 | -9,404 | - |
Other Financing Activities | -585.48 | -849.82 | -1,331 | 462.3 | 903.14 |
Financing Cash Flow | -20,083 | -10,954 | 81,401 | 10,808 | -115.59 |
Foreign Exchange Rate Adjustments | -439.64 | 1,353 | -415.46 | -1,117 | 1,457 |
Net Cash Flow | -32,859 | 13,308 | -103.91 | 10,998 | 578.18 |
Free Cash Flow | -33,082 | 26,646 | -41,946 | -53,448 | -44,522 |
Free Cash Flow Margin | -9.97% | 9.73% | -14.72% | -21.44% | -26.88% |
Free Cash Flow Per Share | -1542.64 | 1366.16 | -2230.12 | -2841.64 | -2385.36 |
Cash Interest Paid | 578.08 | 817.46 | 1,331 | 929.58 | 447.67 |
Cash Income Tax Paid | 8,742 | 4,955 | 2,118 | 2,868 | -826.64 |
Levered Free Cash Flow | -31,057 | 10,548 | -58,932 | -68,609 | -73,918 |
Unlevered Free Cash Flow | -28,534 | 15,384 | -55,116 | -66,817 | -70,695 |
Change in Working Capital | -79,381 | 36,705 | -64,780 | -40,821 | -21,449 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.